These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 15048138)

  • 1. Topical corticosteroid therapy for cicatricial conjunctivitis associated with chronic graft-versus-host disease.
    Robinson MR; Lee SS; Rubin BI; Wayne AS; Pavletic SZ; Bishop MR; Childs R; Barrett AJ; Csaky KG
    Bone Marrow Transplant; 2004 May; 33(10):1031-5. PubMed ID: 15048138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Feasibility and response to budesonide as topical corticosteroid therapy for acute intestinal GVHD.
    Bertz H; Afting M; Kreisel W; Duffner U; Greinwald R; Finke J
    Bone Marrow Transplant; 1999 Dec; 24(11):1185-9. PubMed ID: 10642806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Daclizumab for children with corticosteroid refractory graft-versus-host disease.
    Teachey DT; Bickert B; Bunin N
    Bone Marrow Transplant; 2006 Jan; 37(1):95-9. PubMed ID: 16247417
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduced efficacy of topical corticosteroid in preventing cytarabine-induced kerato-conjunctivitis in patients receiving high-dose cytarabine and total body irradiation for allogeneic hematopoietic stem cell transplantation.
    Mori T; Watanabe M; Kurotori-Sotome T; Ito C; Yamada K; Yashima T; Kobayashi N; Kondo S; Aisa Y; Kato J; Ogawa Y; Tsubota K; Shigematsu N; Kubo A; Ikeda Y; Okamoto S
    Bone Marrow Transplant; 2008 Aug; 42(3):197-9. PubMed ID: 18500372
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of topical cyclosporin A in ocular graft-versus-host-disease.
    Kiang E; Tesavibul N; Yee R; Kellaway J; Przepiorka D
    Bone Marrow Transplant; 1998 Jul; 22(2):147-51. PubMed ID: 9707022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Influence of graft-versus-host disease on long-term survival of 26 patients with hematologic malignancies after transplantation].
    Lin Q; Dong M; Wang QM; Wen JY; Wu XY
    Ai Zheng; 2006 Oct; 25(10):1261-5. PubMed ID: 17059772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase II study of pentostatin in patients with corticosteroid-refractory chronic graft-versus-host disease.
    Jacobsohn DA; Chen AR; Zahurak M; Piantadosi S; Anders V; Bolaños-Meade J; Higman M; Margolis J; Kaup M; Vogelsang GB
    J Clin Oncol; 2007 Sep; 25(27):4255-61. PubMed ID: 17878478
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allogeneic stem cell transplantation in first complete remission enhances graft-versus-leukemia effect in adults with acute lymphoblastic leukemia: antileukemic activity of chronic graft-versus-host disease.
    Lee S; Cho BS; Kim SY; Choi SM; Lee DG; Eom KS; Kim YJ; Kim HJ; Min CK; Cho SG; Kim DW; Lee JW; Min WS; Shin WS; Kim CC
    Biol Blood Marrow Transplant; 2007 Sep; 13(9):1083-94. PubMed ID: 17697971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL
    Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ocular findings after allogeneic hematopoietic stem cell transplantation.
    Tabbara KF; Al-Ghamdi A; Al-Mohareb F; Ayas M; Chaudhri N; Al-Sharif F; Al-Zahrani H; Mohammed SY; Nassar A; Aljurf M
    Ophthalmology; 2009 Sep; 116(9):1624-9. PubMed ID: 19729097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term result of maintenance treatment with tacrolimus ointment in chronic ocular graft-versus-host disease.
    Jung JW; Lee YJ; Yoon SC; Kim TI; Kim EK; Seo KY
    Am J Ophthalmol; 2015 Mar; 159(3):519-27.e1. PubMed ID: 25498356
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Eczematoid graft-vs-host disease: a novel form of chronic cutaneous graft-vs-host disease and its response to psoralen UV-A therapy.
    Creamer D; Martyn-Simmons CL; Osborne G; Kenyon M; Salisbury JR; Devereux S; Pagliuca A; Ho AY; Mufti GJ; du Vivier AW
    Arch Dermatol; 2007 Sep; 143(9):1157-62. PubMed ID: 17875877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of acute graft-versus-host disease following reduced-intensity stem-cell transplantation from an HLA-identical related donor.
    Murashige N; Kami M; Mori S; Katayama Y; Kobayashi K; Onishi Y; Hori A; Kishi Y; Hamaki T; Tajima K; Kanda Y; Tanosaki R; Takaue Y
    Am J Hematol; 2008 Aug; 83(8):630-4. PubMed ID: 18454459
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dry-eye syndrome after allogeneic stem-cell transplantation in children.
    Fahnehjelm KT; Törnquist AL; Winiarski J
    Acta Ophthalmol; 2008 May; 86(3):253-8. PubMed ID: 18093259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low-dose methotrexate for the treatment of graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
    Huang XJ; Jiang Q; Chen H; Xu L; Liu D; Chen Y; Han W; Zhang Y; Liu K; Lu D
    Bone Marrow Transplant; 2005 Aug; 36(4):343-8. PubMed ID: 15968295
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Update on ocular graft versus host disease.
    Kim SK
    Curr Opin Ophthalmol; 2006 Aug; 17(4):344-8. PubMed ID: 16900025
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnosis and treatment of ocular chronic graft-versus-host disease: report from the German-Austrian-Swiss Consensus Conference on Clinical Practice in chronic GVHD.
    Dietrich-Ntoukas T; Cursiefen C; Westekemper H; Eberwein P; Reinhard T; Bertz H; Nepp J; Lawitschka A; Heiligenhaus A; Seitz B; Messmer EM; Meyer-ter-Vehn T; Basara N; Greinix H; Datiles MB; Lee SJ; Pavletic SZ; Wolff D
    Cornea; 2012 Mar; 31(3):299-310. PubMed ID: 22157574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recombinant human soluble tumor necrosis factor receptor fusion protein as treatment for steroid refractory graft-versus-host disease following allogeneic hematopoietic stem cell transplantation.
    Busca A; Locatelli F; Marmont F; Ceretto C; Falda M
    Am J Hematol; 2007 Jan; 82(1):45-52. PubMed ID: 16937391
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Two cases of cutaneous chronic graft versus host disease in treatment with psoralen plus ultraviolet-A-bath photochemotherapy.
    Hoffner MV; Carrizosa Esquivel A; Pulpillo Ruiz A; Herrera Saval A; Conejo-Mir J; Camacho FM
    J Drugs Dermatol; 2009 Nov; 8(11):1027-9. PubMed ID: 19894371
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histological evaluation of acute mucocutaneous graft-versus-host disease in nonmyeloablative hematologic stem cell transplants with an observation predicting an increased risk of progression to chronic graft-versus-host disease.
    Bridge AT; Nelson RP; Schwartz JE; Mirowski GW; Billings SD
    Am J Dermatopathol; 2007 Feb; 29(1):1-6. PubMed ID: 17284954
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.